Avandia | eHealth News

Genetic variants in CYP2C8 and SLCO1B1 impact the therapeutic response to rosiglitazone in patients with type 2 diabetes

CYP2C8, SLCO1B1 Variants Impact Response to Rosiglitazone

HealthDay.com - Jun 10, 2016 0

Genetic variants have clinical impact on response to rosiglitazone, but not pioglitazone

Patients with chronic myeloid leukemia who received a glitazone along with imatinib remained disease-free for up to nearly five years in a study published online Sept. 2 in Nature.

Addition of Glitazone to Chemo May Help Treat CML

HealthDay.com - Sep 3, 2015 0

Combining glitazones with standard treatment improved survival in small study

Use of glitazones may help protect against Parkinson's disease

Glitazone Usage Tied to Lower Risk for Parkinson’s Disease

HealthDay.com - Jul 22, 2015 0

Lower risk of Parkinson's seen only with current use of glitazone

Archives